Search for Clinical Trial Results
Gliosarcoma - 27 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma Condition:
|
Active, not recruiting |
Study Name: Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma Condition:
Date: 2009-07-07 Interventions: Other: Hyperbaric Oxygen Therapy in addition to standard radiation and chemotherapy, you will also recei |
Completed |
Study Name: S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma Condition: Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System Date: 2001-06-06 Interventions:
|
Recruiting |
Study Name: Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme Condition: Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Date: 2013-03-22 Interventions:
|
Recruiting |
Study Name: Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Glioblastoma (GBM) Patients Condition:
Date: 2016-01-14 Interventions:
|
RECRUITING |
Study Name: Engineered NK Cells Containing Deleted TGF-BetaR2 and NR3C1 for the Treatment of Recurrent Glioblastoma Condition: Recurrent Gliosarcoma Date: 2024-05-19 Interventions: Given CB-NK-TGF-betaR2-/NR3C1- intratumorally |
RECRUITING |
Study Name: Engineered NK Cells Containing Deleted TGF-BetaR2 and NR3C1 for the Treatment of Recurrent Glioblastoma Condition: Recurrent Gliosarcoma Date: 2024-05-19 Interventions: Given CB-NK-TGF-betaR2-/NR3C1- intratumorally |